Literature DB >> 3015769

Haplotypes of the human apoprotein AI-CIII-AIV gene cluster in coronary atherosclerosis.

G A Ferns, D J Galton.   

Abstract

Restriction fragment length polymorphisms of the apoprotein AI-CIII-AIV gene cluster (on the long arm of chromosome 11) were investigated in a group of Caucasian survivors of myocardial infarction, using genomic hybridisation analysis. Four common haplotypes were identified at this locus, M1P1S1, M2P1S1, M1P2S1, and M2P1S2; where M1 and M2 are the common and uncommon alleles defined using the restriction enzyme MspI, P1 and P2 are the common and uncommon alleles defined by the enzyme PstI, and S1 and S2 are the common and uncommon alleles defined by the enzyme SstI. Seven genotype combinations were observed of approximate frequencies; a/a 0.70 (33/47), a/d 0.15 (7/47), a/b 0.04 (2/47), d/d 0.04 (2/47), a/c 0.02 (1/47), b/c 0.02 (1/47), and c/d 0.02 (1/47). In contrast the corresponding values for normotriglyceridaemic Caucasian controls, without a personal or family history of atherosclerotic heart disease were; 0.83 (40/48), 0.02 (1/48), 0.06 (3/48), 0, 0.04 (2/48), 0.04 (2/48), and 0. The relative incidence of the d haplotype, characterised by the presence of a cleavage site for the enzyme SstI in the fourth exon of the ApoCIII gene, was significantly higher in the patient group (P less than 0.01). However, because of the tight linkage between the polymorphic loci studied, it was not possible to identify haplotypes associated with any greater risk of premature atherosclerosis than when the SstI polymorphism was considered in isolation.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 3015769     DOI: 10.1007/bf00401237

Source DB:  PubMed          Journal:  Hum Genet        ISSN: 0340-6717            Impact factor:   4.132


  20 in total

1.  On estimating the relation between blood group and disease.

Authors:  B WOOLF
Journal:  Ann Hum Genet       Date:  1955-06       Impact factor: 1.670

2.  DNA sequence polymorphisms in the apolipoprotein A-I/C-III gene cluster.

Authors:  S W Morris; W H Price
Journal:  Lancet       Date:  1985-11-16       Impact factor: 79.321

3.  Genetic polymorphisms of apolipoprotein C-III and insulin in survivors of myocardial infarction.

Authors:  G A Ferns; J Stocks; C Ritchie; D J Galton
Journal:  Lancet       Date:  1985-08-10       Impact factor: 79.321

4.  C-III DNA restriction fragment length polymorphism and myocardial infarction.

Authors:  G A Ferns; J Stocks; D J Galton
Journal:  Lancet       Date:  1986-01-11       Impact factor: 79.321

5.  Multivariate analyses of serum apolipoproteins and risk factors in relation to acute myocardial infarction.

Authors:  G Fager; O Wiklund; S O Olofsson; L Wilhelmsen; G Bondjers
Journal:  Arteriosclerosis       Date:  1981 Jul-Aug

6.  DNA polymorphisms flanking the apo A-1 and insulin genes and type III hyperlipidaemia.

Authors:  M Vella; A Kessling; N Jowett; A Rees; J Stocks; S Wallis; D Galton
Journal:  Hum Genet       Date:  1985       Impact factor: 4.132

7.  Human apolipoproteins AI, AII, CII and CIII. cDNA sequences and mRNA abundance.

Authors:  C R Sharpe; A Sidoli; C S Shelley; M A Lucero; C C Shoulders; F E Baralle
Journal:  Nucleic Acids Res       Date:  1984-05-11       Impact factor: 16.971

8.  High density lipoprotein as a protective factor against coronary heart disease. The Framingham Study.

Authors:  T Gordon; W P Castelli; M C Hjortland; W B Kannel; T R Dawber
Journal:  Am J Med       Date:  1977-05       Impact factor: 4.965

9.  Familial aggregation of coronary heart disease in a high incidence area (North Karelia, Finland).

Authors:  A M Rissanen
Journal:  Br Heart J       Date:  1979-09

10.  Apolipoprotein multigene family: tandem organization of human apolipoprotein AI, CIII, and AIV genes.

Authors:  S K Karathanasis
Journal:  Proc Natl Acad Sci U S A       Date:  1985-10       Impact factor: 11.205

View more
  11 in total

1.  The effects of scale: variation in the APOA1/C3/A4/A5 gene cluster.

Authors:  Stephanie M Fullerton; Anne V Buchanan; Vibhor A Sonpar; Scott L Taylor; Joshua D Smith; Christopher S Carlson; Veikko Salomaa; Jari H Stengård; Eric Boerwinkle; Andrew G Clark; Deborah A Nickerson; Kenneth M Weiss
Journal:  Hum Genet       Date:  2004-04-24       Impact factor: 4.132

2.  Estimation of Hardy-Weinberg and pairwise disequilibrium in the apolipoprotein AI-CIII-AIV gene cluster.

Authors:  M B Haviland; A M Kessling; J Davignon; C F Sing
Journal:  Am J Hum Genet       Date:  1991-08       Impact factor: 11.025

3.  Association analysis of lipid levels and apolipoprotein restriction fragment length polymorphisms.

Authors:  O Myklebost; S Rogne; I Hjermann; B Olaisen; H Prydz
Journal:  Hum Genet       Date:  1990-12       Impact factor: 4.132

4.  DNA haplotypes of the human apoprotein B gene in coronary atherosclerosis.

Authors:  G A Ferns; D Robinson; D J Galton
Journal:  Hum Genet       Date:  1988-12       Impact factor: 4.132

Review 5.  DNA polymorphism and the study of disease associations.

Authors:  D N Cooper; J F Clayton
Journal:  Hum Genet       Date:  1988-04       Impact factor: 4.132

6.  Genetic markers to predict polygenic disease.

Authors:  D J Galton
Journal:  Curr Atheroscler Rep       Date:  1999-09       Impact factor: 5.113

7.  An apolipoprotein CIII marker associated with hypertriglyceridemia in Caucasians also confers increased risk in a west Japanese population.

Authors:  Q Zeng; M Dammerman; Y Takada; A Matsunaga; J L Breslow; J Sasaki
Journal:  Hum Genet       Date:  1995-04       Impact factor: 4.132

8.  Linkage disequilibrium of three polymorphic RFLP markers in the apolipoprotein AI-CIII gene cluster on chromosome 11.

Authors:  O Marasco; F Melina; E Mele; B Quaresima; A Zingone; E Focarelli; E Picciotti; M L Martelli; L Fotino; M F Vigna
Journal:  Hum Genet       Date:  1993-03       Impact factor: 4.132

9.  Apolipoprotein B signal peptide polymorphism in patients with myocardial infarction and controls. "The ECTIM study".

Authors:  S Visvikis; J P Cambou; D Arveiler; A E Evans; H J Parra; D Aguillon; J C Fruchart; G Siest; F Cambien
Journal:  Hum Genet       Date:  1993-01       Impact factor: 4.132

10.  Apolipoprotein gene cluster on chromosome 19. Definite localization of the APOC2 gene and the polymorphic Hpa I site associated with type III hyperlipoproteinemia.

Authors:  M Smit; E van der Kooij-Meijs; R R Frants; L Havekes; E C Klasen
Journal:  Hum Genet       Date:  1988-01       Impact factor: 4.132

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.